Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biovaxys Technology Corp (BIOV.CN)

Biovaxys Technology Corp (BIOV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 16,518
  • Shares Outstanding, K 220,242
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,687 K
  • 60-Month Beta 1.30
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BIOV.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings $0.00 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0500 +40.00%
on 07/17/24
0.0750 -6.67%
on 07/26/24
unch (unch)
since 05/17/24
3-Month
0.0500 +40.00%
on 07/17/24
0.0800 -12.50%
on 05/15/24
-0.0050 (-6.67%)
since 04/26/24
52-Week
0.0100 +600.00%
on 12/14/23
0.1000 -30.00%
on 02/28/24
+0.0500 (+250.00%)
since 07/26/23

Most Recent Stories

More News
Stocks in play: BioVaxys Technology Corp

Announces it intends to complete a non-brokered private placement consisting of up to 10,000,000 units ...

BIOV.CN : 0.0700 (-6.67%)
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT AND DEBT SETTLEMENT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it intends to complete a non-brokered...

BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0537 (+2.68%)
Stocks in play: BioVaxys Technology Corp

Announced the United States Patent and Trademark Office has issued BioVaxys U.S. Patent No. 12,042,537. ...

BIOV.CN : 0.0700 (-6.67%)
BIOVAXYS ANNOUNCES ISSUANCE OF DPX RELATED PATENT FROM THE U.S. PATENT AND TRADEMARK OFFICE

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that the United States Patent and Trademark Office...

BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0537 (+2.68%)
Stocks in play: BioVaxys Technology Corp

Announces it has engaged Brittany Davison, CPA, CA as Business Advisor. Ms. Davison is a Chartered Professional ...

BIOV.CN : 0.0700 (-6.67%)
Brittany Davison, CPA, CA, Joins BioVaxys as Business Advisor

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has engaged Brittany Davison, CPA, CA...

BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0537 (+2.68%)
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF TRIAL TO TEST IMMUNOCONTRACEPTION IN ASIAN ELEPHANTS

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac-for-Wildlife, Inc. ("SpayVac") jointly announce that SpayVac...

BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0537 (+2.68%)
Stocks in play: BioVaxys Technology Corp.

Announced the revocation of the failure to file cease trade order issued by its principal regulator, ...

BIOV.CN : 0.0700 (-6.67%)
BioVaxys Technology Corp. Announces Revocation of Cease Trade Order

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: BVAXF) (the "Company") is pleased to announce the revocation of the failure to file cease trade...

BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0537 (+2.68%)
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") announces that the Ontario Securities Commission (the "OSC") has...

BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0537 (+2.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.

See More

Key Turning Points

3rd Resistance Point 0.0783
2nd Resistance Point 0.0767
1st Resistance Point 0.0733
Last Price 0.0700
1st Support Level 0.0683
2nd Support Level 0.0667
3rd Support Level 0.0633

See More

52-Week High 0.1000
Last Price 0.0700
Fibonacci 61.8% 0.0656
Fibonacci 50% 0.0550
Fibonacci 38.2% 0.0444
52-Week Low 0.0100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar